Frequency and characteristics of docetaxel-induced radiation recall phenomenon

International Journal of Radiation Oncology Biology Physics

Volumn 66, Issue 4, 2006, Pages 1187-1191

  Mizumoto, Masashi ^a   Harada, Hideyuki ^a   Asakura, Hirofumi ^a   Zenda, Sadamoto ^a   Fuji, Hiroshi ^a   Murayama, Shigeyuki ^a   Nishimura, Tetsuo ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Case studies; Docetaxel; Radiation recall phenomenon; Radiotherapy

Indexed keywords

HOSPITALS; PATIENT MONITORING; PHOTONS; TUMORS;

DOCETAXEL; RADIATION RECALL PHENOMENON (RRP);

RADIOTHERAPY;

ANESTHETIC AGENT; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; PACLITAXEL; PREDNISOLONE; RITUXIMAB; TRASTUZUMAB; VINCRISTINE;

ADULT; AGED; ANAMNESIS; ARTICLE; B CELL LYMPHOMA; BRAIN METASTASIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CEREBELLUM; CHRONOTHERAPY; CORTICOSTEROID THERAPY; DERMATITIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FREQUENCY ANALYSIS; HEAD AND NECK TUMOR; HOSPITAL; HUMAN; INCIDENCE; LUNG ADENOCARCINOMA; LUNG METASTASIS; MALE; MUCOSA INFLAMMATION; OROPHARYNX CARCINOMA; PHOTON THERAPY; PRIORITY JOURNAL; RADIATION; RADIATION DOSE; RADIATION ENERGY; RADIATION RECALL PHENOMENON; STOMATITIS; TISSUE REACTION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; NEOPLASMS; RADIATION INJURIES; RADIATION TOLERANCE; RISK ASSESSMENT; RISK FACTORS; TAXOIDS;

EID: 33750308492     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.05.073     Document Type: Article

References (18)

1. Morkas M., Fleming D., and Hahl M. Radiation recall associated with docetaxel. J Clin Oncol 20 (2002) 867-869
2. Mario V. Radiation recall dermatitis after docetaxel administration: Absolute indication to replace the drug?. Br J Dermatol 153 (2005) 674-675
3. Kandemir E.G., Karabudak O., and Maydagli A. Docetaxel-induced radiation recall dermatitis. Swiss Medical Wkly 135 (2005) 34-35
4. Culp L.R., Pou A.M., Jones D.V., et al. A case of radiation recall mucositis associated with docetaxel. Head Neck 26 (2004) 197-200
5. Camidge D.R., and Kunkler I.H. Docetaxel-induced radiation recall dermatitis and successful rechallenge without recurrence. Clin Oncol 12 (2000) 272-273
6. Mustafa S., Melahat G., and Hakan A. Radiation recall effect with docetaxel: Is it a barrier for sandwich approach of radiotherapy sequencing in adjuvant breast cancer treatment?. Turkish J Cancer 31 (2001) 82-86
7. Yeo W., Leung S.F., and Johnson P.J. Radiation recall dermatitis with docetaxel: Establishment of a requisite radiation threshold. Eur J Cancer 33 (1997) 698-699
8. Zulian G.B., and Aapro M.S. Docetaxel and radiation-recall severe mucositis. Ann Oncol 5 (1994) 964
9. National Cancer Institute. National Cancer Institute Common Toxicity Criteria. Available at: http://ctep.info.nih.gov/reporting/index.html.
10. D'Angio G.J., Faber S., and Maddock C.L. Potential of X-rays effect of actinomycin D. Radiology 73 (1959) 175-177
11. Camidge R., and Price A. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol 59 (2001) 237-245
12. David A., Nicolas M., Abderrahim Z., et al. Radiation recall: A well recognized but neglected phenomenon. Cancer Treatment Rev 31 (2005) 555-570
13. Muro K., Hamaguchi T., Ohtsu A., et al. A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer. Ann Oncol 15 (2004) 955-959
14. Posner M.R. Paradigm shift in the treatment of head and neck cancer: The role of neoadjuvant chemotherapy. Oncologist 10 (2005) 11-19
15. Tabernero J., Climent M., Lluch A., et al. A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer. Ann Oncol 15 (2004) 1358-1365
16. Wolfgang S., Sylke N., Thomas B., et al. Phase III study of second-line chemotherapy for advanced non-small cell lung cancer with weekly compared with 3-weekly docetaxel. J Clin Oncol 23 (2005) 8389-8395
17. Kodym E., Kalinska R., Ehringfeld C., et al. Frequency of radiation recall dermatitis in adult cancer patients. Onkologie 28 (2005) 18-21
18. Burdon J., Bell R., Sullivan J., et al. Adriamycin-induced recall phenomenon 15 years after radiotherapy. JAMA 239 (1978) 931